Inovio Pharmaceuticals Inc (INO) — Defensive Interval Ratio
Inovio Pharmaceuticals Inc (INO) has a Defensive Interval Ratio of 80 days as of September 2025. Defensive assets of $15.21 Million (cash $-, short-term investments $14.24 Million, receivables $978.59K) cover 80 days of daily cash needs of $191.30K/day. Check INO goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Inovio Pharmaceuticals Inc Defensive Interval Ratio (1998–2024)
This chart shows how Inovio Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the ratio stands at 80 days, meaning defensive assets of $15.21 Million can fund 80 days of operations without new revenue. Also explore how fast is Inovio Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Inovio Pharmaceuticals Inc (1998–2024)
The table below presents the year-by-year Defensive Interval Ratio for Inovio Pharmaceuticals Inc from 1998 to 2024, covering 27 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see INO market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 305 days | $29.50 Million | $96.78K/day | $- | $28.30 Million | ▼ -839 days |
| 2023 | 1144 days | $133.39 Million | $116.63K/day | $- | $130.98 Million | ▲ +321 days |
| 2022 | 823 days | $218.41 Million | $265.39K/day | $- | $206.67 Million | ▼ -1055 days |
| 2021 | 1878 days | $338.20 Million | $180.11K/day | $- | $330.17 Million | ▲ +303 days |
| 2020 | 1575 days | $179.98 Million | $114.26K/day | $- | $160.91 Million | ▲ +784 days |
| 2019 | 792 days | $69.37 Million | $87.64K/day | $- | $67.34 Million | ▲ +155 days |
| 2018 | 637 days | $61.59 Million | $96.71K/day | $- | $57.54 Million | ▼ -498 days |
| 2017 | 1135 days | $110.13 Million | $97.00K/day | $- | $103.64 Million | ▲ +284 days |
| 2016 | 851 days | $102.20 Million | $120.06K/day | $- | $85.63 Million | ▼ -456 days |
| 2015 | 1307 days | $112.69 Million | $86.21K/day | $- | $105.36 Million | ▼ -141 days |
| 2014 | 1448 days | $55.88 Million | $38.59K/day | $- | $53.08 Million | ▲ +1168 days |
| 2013 | 280 days | $22.21 Million | $79.36K/day | $- | $18.91 Million | ▼ -108 days |
| 2012 | 388 days | $8.90 Million | $22.95K/day | $- | $8.03 Million | ▼ -54 days |
| 2011 | 442 days | $13.37 Million | $30.25K/day | $- | $12.86 Million | ▲ +331 days |
| 2010 | 111 days | $1.95 Million | $17.63K/day | $- | $1.85 Million | ▼ -151 days |
| 2009 | 261 days | $13.86 Million | $53.01K/day | $- | $13.54 Million | ▲ +245 days |
| 2008 | 17 days | $671.19K | $40.30K/day | $- | $- | ▼ -1957 days |
| 2007 | 1974 days | $18.14 Million | $9.19K/day | $- | $17.00 Million | ▲ +1174 days |
| 2006 | 800 days | $15.03 Million | $18.79K/day | $- | $14.70 Million | ▲ +774 days |
| 2005 | 25 days | $284.17K | $11.33K/day | $- | $- | ▼ -4 days |
| 2004 | 29 days | $424.16K | $14.80K/day | $- | $- | ▼ -26 days |
| 2003 | 55 days | $175.00K | $3.17K/day | $- | $- | ▲ +38 days |
| 2002 | 17 days | $75.59K | $4.54K/day | $- | $- | ▼ -835 days |
| 2001 | 852 days | $3.75 Million | $4.40K/day | $- | $2.81 Million | ▼ -43 days |
| 2000 | 895 days | $3.71 Million | $4.14K/day | $- | $2.81 Million | ▲ +701 days |
| 1999 | 194 days | $1.12 Million | $5.77K/day | $- | $- | ▼ -14 days |
| 1998 | 209 days | $800.00K | $3.84K/day | $- | $- | — |